Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.

ABSTRACT:

Background

Cannabis is categorized as an illicit drug in most US states, but legalization for medical indications is increasing. Policies and guidance on cannabis use in transplant patients remain controversial.

Methods

We examined a database linking national kidney transplant records (n = 52 689) with Medicare claims to identify diagnoses of cannabis dependence or abuse (CDOA) and associations [adjusted hazard ratio (aHR) with 95% upper and lower confidence limits (CLs)] with graft, patient, and other clinical outcomes.

Results

CDOA was diagnosed in only 0.5% (n = 254) and 0.3% (n = 163) of kidney transplant recipients in the years before and after transplant, respectively. Patients with pretransplant CDOA were more likely to be 19 to 30 years of age and of black rac

SUBMITTER: Alhamad T 

PROVIDER: S-EPMC6679817 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature